Algert Global’s Bionano Genomics BNGO Stock Holding History

Algert Global’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-35	Closed	-$114K	–	978
2021 Q3	$114K	Sell	35 -23	-40%	-$80.4K	0.02%	958
2021 Q2	$257K	Buy	+58	New	+$229K	0.09%	318

Other funds holding BNGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Algert Global's BNGO Position: Q4 2021 in Review

Algert Global sold out of Bionano Genomics (BNGO) in Q4 2021, closing a stake of 35 shares — an estimated $114K sold.

Algert Global first reported a position in BNGO in Q2 2021 and held it in 2 quarters. The position peaked at $257K in Q2 2021. 149 funds tracked by Wall St. Rank hold BNGO as of Q4 2021.

Algert Global reported no remaining Bionano Genomics position as of Q4 2021 after selling out during the quarter.
Algert Global sold 35 Bionano Genomics shares in Q4 2021, an estimated $114K.
Algert Global first reported a position in Bionano Genomics in Q2 2021 and held it in 2 quarters.
Algert Global's Bionano Genomics position peaked at $257K in Q2 2021.
149 funds tracked by Wall St. Rank held Bionano Genomics as of Q4 2021.

Based on Algert Global's 13F filing for Q4 2021, filed 14 Feb 2022.